Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
Clinical trial NCT03299244 · COMPLETED
Trial details
- NCT number
- NCT03299244
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2020-04-08
- Enrollment
- 637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.